拋棄型針筒市場

Abstract

This TriMark Publications report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volume are used to indicate market sizes. Additionally, this review examines industry challenges and potential threats to syringe and needle supplies manufacturers and makes strategic recommendations for boosting market share. The emphasis is on those companies actively developing and marketing products to hospitals, physicians and the general public for medically related uses. The disposable syringe market segments are identified as: 1) total reusable needle and syringe market; 2) total disposable needle and syringe market; 3) prefilled syringes; 4) safety syringes; 5) insulin injector pens; 6) needleless injectors; 7) vaccination injectors; 8) blood collection needles and syringes; 9) hypodermic needles and syringes market; 10) insulin needles and syringes market; 11) specialty needles and syringes market; and 12) needleless injector market.

Table of Contents

1. Introduction

• 1.1 Statement of Report
• 1.2 About This Report
• 1.3 Scope of the Report
• 1.4 Objectives
• 1.5 Methodology
• 1.6 Executive Summary

2. Disposable Syringe Markets

• 2.1 Overview
• 2.2 Infection Control and Safety
• 2.3 Hospital Consolidations Pressure Companies to Reduce Prices
• 2.4 Needleless Injector Manufacturers Forge Strategic Alliances
• 2.5 Technological Advancements in Disposable Syringes

3. Syringe Market Segments

• 3.1 Overview
  • 3.1.1 World Market
  • 3.1.2 U.S. Market
• 3.2 Total Reusable Needle and Syringe Market
• 3.3 Total Disposable Needle and Syringe Market
  • 3.3.1 Drivers of Safety Syringes
  • 3.3.2 Restraints to Safety Syringes
• 3.4 Pre-filled Syringes
• 3.5 Insulin Injector Pens
• 3.6 Needleless Injectors
• 3.7 Vaccination Injectors
• 3.8 Needle and Syringe Market Trends
  • 3.8.1 Market Segments
  • 3.8.2 Customer Needs
  • 3.8.3 Competitor Analysis
  • 3.8.4 Target Markets for Specialty Syringes
  • 3.8.5 Third Party Reimbursement
  • 3.8.6 Regulation
  • 3.8.7 Drug Discovery Trends
  • 3.8.8 Demographic Shifts
  • 3.8.9 Managed Care Initiatives
  • 3.8.10 Growth in Home Healthcare

4. Technology Development and Sterilization Methods

• 4.1 Disposable Syringes
  • 4.1.1 Autodestruct Syringes
  • 4.1.2 SoloShot™
• 4.2 Monodose Syringes
• 4.3 Pre-filled Syringes
  • 4.3.1 Features of Pre-filled Membrane Syringes
    • 4.3.1.1 Products in Pre-filled Syringes
    • 4.3.1.2 Compatibility of Drug Components
    • 4.3.1.3 Lyophilized Drugs and Powders
    • 4.3.1.4 Dual-chambered Syringes
    • 4.3.1.5 Pre-filled Diluent Syringes
    • 4.3.1.6 Needle Safety Devices for Pre-filled Syringes
    • 4.3.1.7 Sterility Maintenance
  • 4.3.2 Pen Syringes
    • 4.3.2.1 Technical Advances in Pens
    • 4.3.2.2 Advantages of Pens
    • 4.3.2.3 Pen Types and Styles
    • 4.3.2.4 Pre-filled Pens
    • 4.3.2.5 Reusable Pens
    • 4.3.2.6 Device Preparation
    • 4.3.2.7 Autopen
    • 4.3.2.8 Unifine Pentips
  • 4.3.3 Autoject 2
• 4.4 Insulin Syringes
• 4.5 Jet Injectors
• 4.6 Insulin Pens
• 4.7 Uniject™ Injection Device
• 4.8 Microneedle
• 4.9 Needle Free Injection
  • 4.9.1 Hypospray
• 4.10 Glass Pre-fillable Syringes
• 4.11 Retractable Syringe
• 4.12 Ultrasafe Passive Delivery Systems
• 4.13 Ultrasmall Syringes and Microsyringes
• 4.14 Tip Lok® Syringes
• 4.15 Product Profiles
  • 4.15.1 Gettig Guard™
  • 4.15.2 Inviro SNAP! ®
  • 4.15.3 Maxxon Safety Syringe
  • 4.15.4 Monoject Magellan™
  • 4.15.5 Needle-Pro
  • 4.15.6 Point Lok®
  • 4.15.7 SafetyGlide™
• 4.16 SC Injection Technology

5. Business Trends

• 5.1 Market Drivers
• 5.2 Market Prospects
• 5.3 Marketing and Distribution
• 5.4 Competitive Landscape
• 5.5 Business Developments
• 5.6 Acquisitions and Partnerships
• 5.7 Key Players
  • 5.7.1 Kendall
  • 5.7.2 Becton Dickinson
  • 5.7.3 C.R. Bard
  • 5.7.4 International Medication Systems
  • 5.7.5 Terumo Medical Corporation

6. Future Technologies

• 6.1 Thermostable Vaccines and Vaccine Vial Monitors
• 6.2 Sugar Glass
• 6.3 Issues in Technology Transfer for AD Syringes

7. Regulatory Measures

• 7.1 Safety Syringes in Europe
• 7.2 Safety Syringe Regulations and Recommendations
• 7.3 Reimbursement Outlook for Injectables

8. Corporate Profiles

9. Corporate Directory

Appendix 1: FDA Approved Syringe Manufacturers

Appendix 2: NAPPSI Primary and Secondary Prevention: Needlestick Safety Device List

Appendix 3: Ambulatory Care Services OSHA/Safety Device Listing

Appendix 4: Frequently Asked Questions for the Needlestick and Safety Prevention Act

INDEX OF FIGURES

• Figure 3.1: U.S. Safety Needle and Syringe Market
• Figure 6.1: Strategy of the "Sugar Project"

INDEX OF TABLES

• Table 2.1: Global Market for Needles and Syringes, 2001-2010
• Table 3.1: Global Market for Injection Devices by Category
• Table 3.2: Worldwide Dollar Market for Needles and Syringes, 1996-2010
• Table 3.3: Worldwide Unit Market for Needles and Syringes, 1996-2010
• Table 3.4: U.S. Dollar Market for Needles and Syringes, 1999-2010
• Table 3.5: Worldwide Disposable Needle and Syringe Market, 1998 2006
• Table 3.6: Worldwide Market for Disposable Needles and Syringes by Region
• Table 3.7: Worldwide Safety Syringe Unit Sales, 1998 2006
• Table 3.8: Worldwide Safety Syringe Dollar Volume, 1998 2006
• Table 3.9: Share of Worldwide Safety Syringes Market by Competitor
• Table 3.10: Share of Worldwide Market for Safety Syringes by Region
• Table 3.11: Worldwide Pre-filled Syringe Unit Sales, 1998 2010
• Table 3.12: Worldwide Pre-filled Syringe Dollar Volume, 1998 2006
• Table 3.13: Share of Worldwide Pre-filled Syringe Market by Competitor
• Table 3.14: Share of Worldwide Market for Pre-filled Syringes by Region
• Table 3.15: Worldwide Insulin Injector Pen Dollar Volume, 1998 2006
• Table 3.16: Worldwide Market for Needle Free Injectable Drug Delivery Systems, 1996-2005
• Table 3.17: Worldwide Needleless Injector Dollar Volume, 1998 2006
• Table 3.18: Worldwide Vaccination Injector Unit Sales, 1998 2006
• Table 3.19: Share of Worldwide Market for Vaccination Injectors by Region
• Table 3.20: Worldwide Vaccination Injector Dollar Volume, 1998 2006
• Table 3.21: Share of Worldwide Vaccination Injector Market by Competitor
• Table 3.22: Summary of Strengths and Weaknesses of Available Syringes
• Table 3.23: Annual Change Per Capita in Healthcare Spending and Gross Domestic Product, 1994 2004
• Table 4.1: Injection Data Using Soloshot and Disposable Syringes
• Table 4.2: Summary Data for Doses by Soloshot and Disposable Syringes
• Table 4.3: Wastage Analysis (Per Vial Used)
• Table 4.4: Important Injectable Drug Therapies Using Pre-filled Devices
• Table 4.5: Region-wise Market of Pre-filled Syringes
• Table 4.6: Worldwide Pre-filled Syringe Unit Sales, 1998 2006
• Table 4.7: Worldwide Pre-filled Syringe Dollar Volume, 1998 2004
• Table 4.8: Insulin Delivery Systems Percent Retail Market Share
• Table 4.9: Insulin Delivery Systems Percent Retail Market Share by Company
• Table 4.10: Commonly-Available Insulin Syringes
• Table 4.11: Features of Available Insulin Pumps
• Table 4.12: Features of Available Jet Injectors
• Table 4.13: Currently Available Insulin Delivery Pens
• Table 4.14: Summary of Clinical and Field Experience with the Uniject Device